NCT00094627View on ClinicalTrials.gov

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

April 30, 2006

Conditions
Primary Insomnia
Interventions
DRUG

gaboxadol

Duration of Treatment - 6 weeks

DRUG

Comparator: placebo (unspecified)

Duration of Treatment - 6 weeks

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00094627 - Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED) | Biotech Hunter | Biotech Hunter